ClinicalTrials.gov

ClinicalTrials.gov is the publicly searchable registry, maintained by the United States National Library of Medicine, where clinical trials are recorded with their design, declared phase, sponsor, and current status — before results, if any, are ever published.

Registration became a legal requirement for most trials involving FDA-regulated products after 2007, and many journals now require prospective registration as a condition of publication. A record on the registry does not summarise findings; it documents that a trial was initiated and tracks its reported progress.

On these pages it appears most often as a gap marker. When no registration exists for a compound, that absence means formal human study has not been initiated — not that study was attempted and returned nothing.

What this design can establish

A registry record establishes that a trial was started, who sponsored it, what phase it reached, and what its declared design was. Phase designations carry specific meaning: Phase I trials assess safety and dosing in small groups; Phase II and III address efficacy at progressively larger scales; Phase IV covers post-market surveillance.

When results are submitted to the registry — which federal law requires for many trial types within a set window after completion — the record can show what outcomes were measured and what the reported findings were. Because the trial design is already on file, it is possible to ask whether the reported outcome follows from the method used.

What it cannot

Registration on its own says nothing about what a trial found. Many trials complete and submit no results; the registry then shows a status but no outcome. A trial whose results are posted here may also reach different conclusions than the peer-reviewed publication of the same data — the two can diverge.

The inference a reader is most likely to draw — that no record means a study ran and came back negative — is wrong in a specific way. An absent registration means the compound has not entered formal clinical study under registered conditions. It says nothing about pre-clinical work, informal observational records, or research conducted under frameworks that do not require registry entry.

The registry is also not an appraisal. A Phase III trial in a carefully selected population answers whether a treatment can work under controlled conditions; it cannot say how that treatment performs across broader populations, or alongside other substances excluded from the trial by design.